Free Trial

Sona Asset Management US LLC Takes Position in SelectQuote, Inc. (NYSE:SLQT)

SelectQuote logo with Finance background

Sona Asset Management US LLC bought a new position in SelectQuote, Inc. (NYSE:SLQT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 765,191 shares of the company's stock, valued at approximately $2,847,000. Sona Asset Management US LLC owned approximately 0.45% of SelectQuote at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. grew its stake in shares of SelectQuote by 36.9% during the third quarter. JPMorgan Chase & Co. now owns 429,656 shares of the company's stock valued at $932,000 after buying an additional 115,865 shares during the last quarter. Barclays PLC grew its stake in shares of SelectQuote by 166.8% during the third quarter. Barclays PLC now owns 198,357 shares of the company's stock valued at $430,000 after buying an additional 124,005 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in SelectQuote by 35.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,055,860 shares of the company's stock worth $3,929,000 after purchasing an additional 275,593 shares in the last quarter. SG Americas Securities LLC grew its stake in SelectQuote by 10.5% in the fourth quarter. SG Americas Securities LLC now owns 91,508 shares of the company's stock worth $340,000 after purchasing an additional 8,660 shares in the last quarter. Finally, Oppenheimer & Co. Inc. bought a new position in SelectQuote in the fourth quarter worth approximately $47,000. 34.59% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at SelectQuote

In other news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $5.44, for a total transaction of $272,000.00. Following the completion of the sale, the insider now owns 1,166 shares in the company, valued at approximately $6,343.04. This represents a 97.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 11.40% of the company's stock.

SelectQuote Trading Down 1.3%

NYSE:SLQT traded down $0.03 during midday trading on Monday, hitting $2.26. The stock had a trading volume of 732,732 shares, compared to its average volume of 1,414,041. The company has a quick ratio of 6.36, a current ratio of 6.36 and a debt-to-equity ratio of 2.10. The company has a market capitalization of $390.35 million, a price-to-earnings ratio of -25.11 and a beta of 1.26. The stock has a 50-day moving average of $3.17 and a 200 day moving average of $3.51. SelectQuote, Inc. has a one year low of $1.62 and a one year high of $6.86.

SelectQuote (NYSE:SLQT - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $408.16 million for the quarter, compared to the consensus estimate of $412.83 million. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. As a group, sell-side analysts forecast that SelectQuote, Inc. will post -0.07 EPS for the current year.

Analyst Ratings Changes

Separately, Noble Financial raised SelectQuote to a "strong-buy" rating in a research note on Wednesday, February 12th.

Get Our Latest Research Report on SelectQuote

SelectQuote Profile

(Free Report)

SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.

Read More

Institutional Ownership by Quarter for SelectQuote (NYSE:SLQT)

Should You Invest $1,000 in SelectQuote Right Now?

Before you consider SelectQuote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.

While SelectQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines